Merz Pharma

The Merz Pharma GmbH & Co. KGaA is a medium sized pharmaceutical company with headquarters in Frankfurt am Main. Merz Pharma is like Senator GmbH & Co. KGaA, a manufacturer of writing instruments, the Merz Group.

The company is a member of the Association of Research- Based Pharmaceutical Companies. It produces medicines for diseases of the central nervous system and metabolism as well as for clinical and aesthetic dermatology. The most important product is memantine for the treatment of Alzheimer 's disease. In addition to prescription drugs, the company provides, under the brand name tetesept and Merz Spezial ( cf. Merz Spezial Dragees ) and OTC preparations forth.

Merz has offices in England, France, Italy, Switzerland, Austria, Spain, USA, Mexico, Russia, Korea, Singapore, Taiwan, and a joint venture in Portugal.

The company Merz Pharma

Merz Pharma is a company with its own research and development. The company combines the global activities of its subsidiaries Merz Pharmaceuticals, Merz Consumer Care, Merz Hygiene and Merz Dental with products ranging from prescription drugs and OTC products to promote health and well-being to materials for dentists and dental technicians.

Merz Pharmaceuticals - Medicinal products for the central nervous system (CNS) and Dermatology

Merz Pharmaceuticals focuses with its own research and development in drugs for neurological and psychiatric disorders such as Alzheimer's dementia, Parkinson 's disease and neuromuscular disorders such as dystonia and spasticity and tinnitus. In the treatment of moderate to severe Alzheimer 's dementia Merz is one of the three leading manufacturers worldwide.

The aesthetic dermatology is the second core competency of Merz. This is about beautifying the appearance by smoothing the skin. In addition, the company develops and markets in so-called clinical range medications that are used to treat scars, acne, hair loss and fungal diseases.

In fiscal year 2012/13 Merz invested 112.8 (2011/ 12: EUR 125.3 ) million euros in the pharmaceutical research and development.

Main products of Merz Pharmaceuticals

  • Ebixa ( Alzheimer's)
  • PK -Merz ( Parkinson )
  • Solvex (depression )
  • Contractubex / Mederma (scar )
  • Naftin ( fungal infections)
  • Pantogar / Pantovigar (hair loss)
  • Pantostin (hair loss)
  • Patentex ( contraceptive )
  • Hyal - System ( folding)
  • Hepa -Merz (liver- related brain disorders )
  • Lipo -Merz retard ( dyslipidemia )
  • Xeomin ( blepharospasm, cervical dystonia of a predominantly rotational )

Merz Consumer Care

Merz Consumer Care develops health, beauty and wellness products under the brand names Merz Spezial (eg Merz Spezial Dragees ) and tetesept are sold.

The development of self-care products focused on preparations for the prevention of diseases and the treatment of everyday ailments and mood disorders as well as dermopharmaceutical products.

Merz produced bath products ( Balneology ), remedy for colds, vitamins, minerals and supplements for skin, hair and fingernails.

Merz Hygiene

Merz Hygiene specializes in the development of disinfection, cleaning and care products for hospitals, medical practices and laboratories.

Merz Dental

Merz Dental, headquartered in Luetjenburg / Schleswig -Holstein designs and manufactures fully anatomical teeth and provides for dentists and dental technicians filling materials, cements and impression materials as well as products for the prophylaxis and hygiene.

History

The company was founded by Friedrich Merz is in the third generation privately owned by the families Adam, Nick and Hückmann and committed suicide in 2008, its 100th anniversary. The table below shows the major milestones.

565421
de